EUVIMEDEUVIMED entdecken
Crossref

Green Synchronous Spectrofluorimetric Analysis of Methotrxate, With 6‐Mercaptopurine as Add‐On Therapy of Childhood Acute Lymphoblastic Leukemia: Application in Laboratory Prepared Mixtures, Spiked Human Plasma, and Dosage Forms

Hesham Salem iD, Michael Amir, Omar Saied, Asmaa A Hamed, Maemona Mamdouh, Noha Khalid, Nadin Mohasen, Gehad Alaswad, Mahmoud Abdelgalil, Ramy M Elsabaa

Luminescence · 2025

DOI: 10.1002/bio.70265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Hesham Salem und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt. Hauptthemen laut MEDLINE: Mercaptopurine, Methotrexate, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Antimetabolites, Antineoplastic. Die Arbeit nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It was the first time that a spectrofluorimetric approach for the simultaneous analysis of methotrexate (MET) and 6‐mercaptopurine (6‐MP) had been achieved. This study aims to propose an accurate and sensitive second derivative synchronous spectrofluorimetric approach for the measurement of MET and 6‐MP in different matrices simultaneously without the need for prior separation. The proposed approach measured the synchronous fluorescence intensity of pharmaceuticals under research at a constant wavelength difference (Δλ) = 130 nm. For the quantitative analysis of 6‐MP and MET, the second derivative's peak amplitudes were observed at 380 and 400 nm, respectively. The process was fully validated and showed exceptional linearity for either 6‐MP or MET in the concentration range of 10–100 ng mL −1 . The new method was used to quantitatively analyze both drugs in a synthetically formulated mixture, dosage forms, and spiked human plasma. A statistical comparison of the results with other published analytical techniques revealed no significant difference. The validation of the procedure was successfully completed in compliance with ICH guidelines. To assess the analytical methodology's greenness, Eco‐Scale and GAPI greenness tools were employed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MercaptopurineMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaAntimetabolites, AntineoplasticHumansSpectrometry, FluorescenceChildDosage Forms

Stichwörter der Autor:innen

6‐mercaptopurineGAPI greenness assessmenteco‐scalemethotrexatesynchronous fluorescence

Substanzen

MercaptopurineMethotrexateAntimetabolites, AntineoplasticDosage Forms

Autor:innen und Institutionen

  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
  • Clinical Pharmacy Department, Faculty of Pharmacy, New Valley University, New Valley, Egypt.
  • Sednawi Children's Hospital, Zagazig University, Zagazig, Egypt.
  • Clinical Pharmacy Department, Faculty of Pharmacy, Menoufia University, Shibin El Kom, Egypt.

ORCID-Profile: Hesham Salem

Zitieren

APA

Salem, H., Amir, M., Saied, O., Hamed, A. A., Mamdouh, M., Khalid, N., Mohasen, N., Alaswad, G., Abdelgalil, M., & Elsabaa, R. M. (2025). Green Synchronous Spectrofluorimetric Analysis of Methotrxate, With 6‐Mercaptopurine as Add‐On Therapy of Childhood Acute Lymphoblastic Leukemia: Application in Laboratory Prepared Mixtures, Spiked Human Plasma, and Dosage Forms. Luminescence. https://doi.org/10.1002/bio.70265

Vancouver

Salem H, Amir M, Saied O, Hamed AA, Mamdouh M, Khalid N, et al. Green Synchronous Spectrofluorimetric Analysis of Methotrxate, With 6‐Mercaptopurine as Add‐On Therapy of Childhood Acute Lymphoblastic Leukemia: Application in Laboratory Prepared Mixtures, Spiked Human Plasma, and Dosage Forms. Luminescence. 2025. doi:10.1002/bio.70265

BibTeX
@article{Salem2025,
  author = {Salem, Hesham and Amir, Michael and Saied, Omar and Hamed, Asmaa A and Mamdouh, Maemona and Khalid, Noha and Mohasen, Nadin and Alaswad, Gehad and Abdelgalil, Mahmoud and Elsabaa, Ramy M},
  title = {Green Synchronous Spectrofluorimetric Analysis of Methotrxate, With 6‐Mercaptopurine as Add‐On Therapy of Childhood Acute Lymphoblastic Leukemia: Application in Laboratory Prepared Mixtures, Spiked Human Plasma, and Dosage Forms},
  journal = {Luminescence},
  year = {2025},
  doi = {10.1002/bio.70265}
}
Kostenlos starten →